Inetetamab is a humanized monoclonal antibody targeting HER2 receptor domain IV, exhibiting antitumor activity through inducing pyroptosis in lung adenocarcinoma. It is used in studies of HER2-positive metastatic breast cancer.
Purity:
96.54%
Target:
EGFR|||HER
* VAT and and shipping costs not included. Errors and price changes excepted
